Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancer
{{output}}
Context: Second-generation androgen receptor inhibitors (ARIs) extend metastasis-free survival, prolong overall survival, and delay symptoms when added to androgen deprivation therapy for the treatment of castration-sensitive or ... ...
